SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

IOL Chemicals planning to invest Rs 200 crore over next two years

14 Nov 2017 Evaluate

IOL Chemicals & Pharmaceuticals is planning to pump in about Rs 200 crore over the next two years in expanding its existing manufacturing capacities including its flagship product, Ibuprofen from 7200 TPA to 12000 TPA, keeping in view the recent approvals from US and Europe.

Presently, the company is also in the process of setting up of a Greenfield facility of producing anti-diabetic product i.e Metformin, at Barnala, Punjab with a capex of Rs 10 crore which will be met from internal accruals and likely to be completed during current financial year.

The company has recently enhanced Ibuprofen capacity from 6200 TPA to 7200 TPA, which is adequately used presently. The company has also completed and commercialized Unit III to manufacture Fenofibrate, Clopidogrel and Lamotrigine etc. with an investment of Rs 16.48 crore met through internal accruals.

The Ibuprofen manufacturing facilities have been approved by US Food and Drug Administration (USFDA), EDQM, WHO. The company is already exporting its Ibuprofen in regulated & Emerging markets i.e. Europe, Latin America, Middle East, etc and with the approval from USFDA, the company is exploring its business in USA.



IOL Chem & Pharma Share Price

96.98 -0.90 (-0.92%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×